Sullivan
Microsoft has discontinued support for Internet Explorer. To access the Sullivan website, please install a modern browser like Microsoft Edge or Google Chrome.

Biography

News

News

Biotech Focused On Developing Non-Opioid Therapeutics to Alleviate Pain Announced IPO

Sullivan was issuer's counsel for Chromocell Therapeutics Corporation, a clinical-stage biotech company focused on developing and commercializing new, non-opioid therapeutics to alleviate pain, in their $6.6 million initial public offering of common stock.

The Sullivan team was led by David Danovitch, director of the firm’s Corporate Department, with partners Charles E. Chambers Jr., Aaron Schleicher and associate Brian Hurley. Sullivan has developed a strength in working with entrepreneurial biotech and tech companies in the U.S. and in Israel.

David E. Danovitch, Charles E. Chambers Jr. and Brian P. Hurley

Past Events

Sullivan Advises Lake Street Capital Markets as Underwriter on $25 Million NeoVolta Public Offering
When: June 2, 2026
People: Angela Gomes, David E. Danovitch, Michael DeDonato, Zachary Sobel and Karly Roux
SEC Turns the Spotlight On Nasdaq Delisting Standards
When: May 1, 2026
People: David E. Danovitch
SEC, FINRA Cross-Border Crackdown Typifies Trump 2.0 Priorities
When: November 4, 2025
People: David E. Danovitch
Sullivan & Worcester Announces Creation of Small-Firm Task Force to Address Latest FINRA Small-Cap IPO Sweep
When: October 24, 2025
People: David E. Danovitch, Michael T. Dyson and Meghan Rohan
Irish Firms 'Very Attractive to Investors' – Leading Law Firm Highlights Benefits of US Capital Markets
When: February 14, 2025
People: Aidan F. Browne, Douglas S. Stransky, David E. Danovitch and Benjamin J. Armour
Sullivan Ranks High in PlacementTracker's Q2 2024 PIPE and Private Placement Markets League Tables
When: August 7, 2024
People: Howard E. Berkenblit, David E. Danovitch, Oded Har-Even, Ron Ben-Bassat and Eric Victorson
Sullivan & Worcester's Growing NYC Office
When: May 2, 2024
People: David E. Danovitch
Sullivan, One of the Top 200 Law Firms in the US, Wants to Help Irish Companies Raise Capital in America
When: April 2, 2024
People: Aidan F. Browne, Benjamin J. Armour and David E. Danovitch
Firm Statement on Developing News in Israel
When: October 7, 2023
People: Joel R. Carpenter, David J. Nagle, David E. Danovitch, Oded Har-Even and Reut Alfiah
Sullivan Advises Mount Rainier Acquisition Corp. in HUB Cyber Security Merger
When: March 23, 2022
People: Reut Alfiah, Tamir Chagal, Gal Cohen, Oded Har-Even and David E. Danovitch
Media Coverage - MAM Software Acquisition
When: September 4, 2019
People: Benjamin J. Armour, David E. Danovitch, Michael DeDonato and David A. Guadagnoli